ANDRES MANUEL R CERVANTES RUIPEREZ-rekin lankidetzan egindako argitalpenak (9)

2023

  1. The percentage of mesorectal infiltration as a prognostic factor after curative surgery for pT3 rectal cancer

    Colorectal Disease, Vol. 25, Núm. 6, pp. 1135-1143

2020

  1. Impact of perioperative transfusions and sepsis on long-term oncologic outcomes after curative colon cancer resection. A retrospective analysis of a prospective database

    Gastroenterologia y Hepatologia, Vol. 43, Núm. 2, pp. 63-72

2019

  1. Prognostic Impact of pT Stage and Peritoneal Invasion in Locally Advanced Colon Cancer

    Diseases of the Colon and Rectum, Vol. 62, Núm. 6, pp. 684-693

2018

  1. Integrating Downstaging in the Risk Assessment of Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: Validation of Valentini's Nomograms and the Neoadjuvant Rectal Score

    Clinical Colorectal Cancer, Vol. 17, Núm. 2, pp. 104-112.e2

2017

  1. Stents metálicos autoexpandibles como puente a la cirugía en el tratamiento del cáncer de colon izquierdo en oclusión. Análisis coste-beneficio y resultados oncológicos

    Cirugia Espanola, Vol. 95, Núm. 3, pp. 143-151

2015

  1. Selective approach for upper rectal cancer treatment: Total mesorectal excision and preoperative chemoradiation are seldom necessary

    Diseases of the Colon and Rectum, Vol. 58, Núm. 6, pp. 556-565

2012

  1. Pathological evaluation of mesocolic resection quality and ex vivo methylene blue injection: What is the impact on lymph node harvest after colon resection for cancer?

    Diseases of the Colon and Rectum, Vol. 55, Núm. 2, pp. 197-204

  2. T4a and T4b Colorectal cancer: What does this mean nowadays

    Diseases of the Colon and Rectum

2011

  1. Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer

    Cancer, Vol. 117, Núm. 14, pp. 3118-3125